The Thrombus Innovation Awards are designed to highlight projects that demonstrate innovation and excellence and have improved the delivery of services to patients with venous/arterial thrombosis. The Awards ceremony is an opportunity to provide recognition of projects that have helped patients, and have the potential to be expanded and adopted elsewhere. Prizes are awarded to the top three entries.

The 2011 ceremony was held on 22 November at the Royal Society of Medicine in London, with prizes of £5,000, £2,000 and £1,000 presented by Peter Rose, Editor of Thrombus and Consultant Haematologist at Warwick Hospital.

Winner
‘Introducing a new approach to providing patient information relating to oral anticoagulant therapy’
University Hospital Southampton NHS Foundation Trust

Second prize
‘An iPhone app for thrombosis and anticoagulation guidelines’
Guy’s and St Thomas’ NHS Foundation Trust

Third prize
‘West Midlands Venous Thromboembolism Quality Observatory’
Queen Elizabeth Hospital Birmingham

To find out more about the three winning – and two highly commended – entries, download the Awards supplement.

The 2011 Thrombus Innovation Awards were organised by Hayward Medical Communications and supported by Boehringer Ingelheim Ltd.

  • The team from University Hospital Southampton NHS Foundation Trust receive their prize for first place
  • The team from Guy’s and St Thomas’ NHS Foundation Trust receive their prize for second place
  • The team from Queen Elizabeth Hospital Birmingham receive their prize for third place
  • The team from Whaddon Medical Centre, Milton Keynes, receive their certificate for their highly commended project
  • The team from Addenbrooke’s Hospital, Cambridge, receive their certificate for their highly commended project
  • Dr Patrick Kesteven delivers his guest lecture



Thrombus is funded by an unrestricted educational grant from Bayer HealthCare, with no editorial input into the contents of this journal.

Thrombus was previously supported by Boehringer Ingelheim from 2009 to 2013, by sanofi-aventis from 2007 to 2008 and by Leo Pharma from 1998 to 2006.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsor, publisher, Editor or Editorial Board. Accordingly the sponsor, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Thrombus is the property of Hayward Group Ltd and, together with the content, is bound by copyright. Copyright © 2017 Hayward Group Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk

ISSN 1369-8117 (Print)  ISSN 2045-7855 (Online)